Literature DB >> 21442303

The blood-brain barrier permeability of geissoschizine methyl ether in Uncaria hook, a galenical constituent of the traditional Japanese medicine yokukansan.

Sachiko Imamura1, Masahiro Tabuchi, Hirotaka Kushida, Akinori Nishi, Hitomi Kanno, Takuji Yamaguchi, Kyoji Sekiguchi, Yasushi Ikarashi, Yoshio Kase.   

Abstract

Geissoschizine methyl ether (GM) in Uncaria hook, a galenical constituent of yokukansan is thought to be one of active components in the psychotropic effect of yokukansan, a traditional Japanese medicine (kampo medicine). However, there is no data on the blood-brain barrier (BBB) permeability of Uncaria hook-derived alkaloids containing GM. In this study, we investigated the BBB permeability of seven Uncaria hook alkaloids (GM, isocorynoxeine, isorhynchophylline, hirsuteine, hirsutine, rhynchophylline, and corynoxeine) using in vivo and in vitro methods. In the in vivo experiment, seven alkaloids in the plasma and brain of rats orally administered with yokukansan were measured by liquid chromatography-mass spectroscopy/mass spectrometric multiple reaction monitoring assay. In the in vitro experiment, the BBB permeability of seven alkaloids were examined using the BBB model composed of co-culture of endothelial cells, pericytes, and astrocytes. In the in vivo study, six components containing GM but not isocorynoxeine were detected in the plasma, and three (GM, hirsuteine, and corynoxeine) of components were detected in the brain. The in vitro BBB permeability data indicated that seven alkaloids were able to cross brain endothelial cells in culture conditions and that the BBB permeability of GM was higher than those of the other six alkaloids. These results suggest that target ingredient GM in yokukansan administered orally is absorbed into the blood and then reaches the brain through the BBB. This evidence further supports the possibility that GM is an active component in the psychotropic effect of yokukansan.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21442303     DOI: 10.1007/s10571-011-9676-3

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  17 in total

1.  Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models.

Authors:  M P Dehouck; P Jolliet-Riant; F Brée; J C Fruchart; R Cecchelli; J P Tillement
Journal:  J Neurochem       Date:  1992-05       Impact factor: 5.372

Review 2.  Astrocyte-endothelial interactions at the blood-brain barrier.

Authors:  N Joan Abbott; Lars Rönnbäck; Elisabeth Hansson
Journal:  Nat Rev Neurosci       Date:  2006-01       Impact factor: 34.870

Review 3.  Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology.

Authors:  Máiria A Deli; Csongor S Abrahám; Yasufumi Kataoka; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

4.  Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies.

Authors:  Koh Iwasaki; Masahiro Maruyama; Naoki Tomita; Katsutoshi Furukawa; Miyako Nemoto; Hironori Fujiwara; Takashi Seki; Masahiko Fujii; Manabu Kodama; Hiroyuki Arai
Journal:  J Clin Psychiatry       Date:  2005-12       Impact factor: 4.384

Review 5.  The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors:  Berislav V Zlokovic
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

Review 6.  Endothelial cells of the brain and other organ systems: some similarities and differences.

Authors:  F Joó
Journal:  Prog Neurobiol       Date:  1996-02       Impact factor: 11.685

7.  Adrenomedullin regulates blood-brain barrier functions in vitro.

Authors:  B Kis; M A Deli; H Kobayashi; C S Abrahám; T Yanagita; H Kaiya; T Isse; R Nishi; S Gotoh; K Kangawa; A Wada; J Greenwood; M Niwa; H Yamashita; Y Ueta
Journal:  Neuroreport       Date:  2001-12-21       Impact factor: 1.837

8.  Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages.

Authors:  Szilvia Veszelka; Mária Pásztói; Attila E Farkas; István Krizbai; Thi Khue Dung Ngo; Masami Niwa; Csongor S Abrahám; Mária A Deli
Journal:  Neurochem Int       Date:  2006-09-25       Impact factor: 3.921

9.  A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.

Authors:  Koh Iwasaki; Takuma Satoh-Nakagawa; Masahiro Maruyama; Yasutake Monma; Miyako Nemoto; Naoki Tomita; Haruko Tanji; Hironori Fujiwara; Takashi Seki; Masahiko Fujii; Hiroyuki Arai; Hidetada Sasaki
Journal:  J Clin Psychiatry       Date:  2005-02       Impact factor: 4.384

10.  A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia.

Authors:  Katsuyoshi Mizukami; Takashi Asada; Toru Kinoshita; Katsuaki Tanaka; Kazuki Sonohara; Ryuhei Nakai; Kiyoshi Yamaguchi; Haruo Hanyu; Kiyoshi Kanaya; Tetsuya Takao; Masakatsu Okada; Sumio Kudo; Hayato Kotoku; Masahiko Iwakiri; Hirofumi Kurita; Toshihiro Miyamura; Yosuke Kawasaki; Koji Omori; Kazumasa Shiozaki; Toshinari Odawara; Tatsuya Suzuki; Shizuru Yamada; Youichi Nakamura; Kenji Toba
Journal:  Int J Neuropsychopharmacol       Date:  2008-12-11       Impact factor: 5.176

View more
  30 in total

Review 1.  In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.

Authors:  Hans C Helms; N Joan Abbott; Malgorzata Burek; Romeo Cecchelli; Pierre-Olivier Couraud; Maria A Deli; Carola Förster; Hans J Galla; Ignacio A Romero; Eric V Shusta; Matthew J Stebbins; Elodie Vandenhaute; Babette Weksler; Birger Brodin
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-11       Impact factor: 6.200

2.  BBB-permeable aporphine-type alkaloids in Nelumbo nucifera flowers with accelerative effects on neurite outgrowth in PC-12 cells.

Authors:  Mamiko Yano; Souichi Nakashima; Yoshimi Oda; Seikou Nakamura; Hisashi Matsuda
Journal:  J Nat Med       Date:  2019-11-09       Impact factor: 2.343

3.  Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia.

Authors:  Taichi Nomura; Yoshio Bando; Hua You; Tatsuhide Tanaka; Shigetaka Yoshida
Journal:  Neurochem Res       Date:  2017-09-19       Impact factor: 3.996

4.  The blood-brain barrier permeability of 18β-glycyrrhetinic acid, a major metabolite of glycyrrhizin in Glycyrrhiza root, a constituent of the traditional Japanese medicine yokukansan.

Authors:  Masahiro Tabuchi; Sachiko Imamura; Zenji Kawakami; Yasushi Ikarashi; Yoshio Kase
Journal:  Cell Mol Neurobiol       Date:  2012-04-10       Impact factor: 5.046

5.  Quantitative imaging of natural products in fine brain regions using desorption electrospray ionization mass spectrometry imaging (DESI-MSI): Uncaria alkaloids as a case study.

Authors:  Lei Gao; Zijia Zhang; Wenyong Wu; Yanping Deng; Haijuan Zhi; Huali Long; Min Lei; Jinjun Hou; Wanying Wu; De-An Guo
Journal:  Anal Bioanal Chem       Date:  2022-05-31       Impact factor: 4.142

Review 6.  Cell-culture models of the blood-brain barrier.

Authors:  Yarong He; Yao Yao; Stella E Tsirka; Yu Cao
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

7.  Effects of geissoschizine methyl ether, an indole alkaloid in Uncaria hook, a constituent of yokukansan, on human recombinant serotonin 7 receptor.

Authors:  Toshiyuki Ueki; Akinori Nishi; Sachiko Imamura; Hitomi Kanno; Kazushige Mizoguchi; Kyoji Sekiguchi; Yasushi Ikarashi; Yoshio Kase
Journal:  Cell Mol Neurobiol       Date:  2012-09-12       Impact factor: 5.046

8.  Geissoschizine methyl ether protects oxidative stress-mediated cytotoxicity in neurons through the 'Neuronal Warburg Effect'.

Authors:  Jiahong Sun; Xuefang Ren; Wen Qi; Dan Yuan; James W Simpkins
Journal:  J Ethnopharmacol       Date:  2016-04-22       Impact factor: 4.360

9.  The Kampo medicine Yokukansan (YKS) enhances nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells.

Authors:  Kazuki Terada; Yukari Matsushima; Kazuhisa Matsunaga; Jiro Takata; Yoshiharu Karube; Atsushi Ishige; Koji Chiba
Journal:  Bosn J Basic Med Sci       Date:  2018-08-01       Impact factor: 3.363

10.  Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer's Disease.

Authors:  Ruiling Xu; Junying Wang; Juanjuan Xu; Xiangrong Song; Hai Huang; Yue Feng; Chunmei Fu
Journal:  Int J Nanomedicine       Date:  2020-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.